Erasca (ERAS) Expected to Announce Earnings on Wednesday

Erasca (NASDAQ:ERAS) is expected to release its earnings data before the market opens on Wednesday, March 26th. Analysts expect Erasca to post earnings of ($0.12) per share for the quarter.

Erasca Stock Performance

Shares of NASDAQ:ERAS opened at $1.44 on Wednesday. Erasca has a one year low of $1.23 and a one year high of $3.45. The business’s fifty day moving average price is $1.70 and its two-hundred day moving average price is $2.39. The stock has a market cap of $407.13 million, a PE ratio of -1.73 and a beta of 1.22.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ERAS shares. Morgan Stanley restated an “overweight” rating and set a $4.00 price objective on shares of Erasca in a report on Friday, March 7th. Bank of America upgraded Erasca from a “neutral” rating to a “buy” rating and set a $5.00 price objective on the stock in a report on Tuesday, January 7th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $4.90.

Erasca Company Profile

Erasca, Inc, a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company’s lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma.